Fungemia caused by non-Candida species

Journal of Microbiology, Immunology and Infection

Volumn 45, Issue 3, 2012, Pages 262-263

  Lai, Chih Cheng ^a   Gau, Shiow Jen ^a   Hsueh, Po Ren ^b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT;

ANTIFUNGAL SUSCEPTIBILITY; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA; CANDIDA ALBICANS; CATHETER REMOVAL; CRYPTOCOCCUS LAURENTII; CRYPTOCOCCUS NEOFORMANS; DIABETES MELLITUS; FUNGEMIA; FUSARIUM; HUMAN; LETTER; LIVER CIRRHOSIS; MORTALITY; NONHUMAN; PENICILLIUM; PREVALENCE; RHODOTORULA; TRICHOSPORON;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; FEMALE; HUMANS; MALE;

EID: 84861232371     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.01.013     Document Type: Letter

References (4)

1. Chi H.W., Yang Y.S., Shang S.T., Chen K.H., Yeh K.M., Chang F.Y., et al. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome. J Microbiol Immunol Infect 2011, 44:369-375.
2. Arendrup M.C., Sulim S., Holm A., Nielsen L., Nielsen S.D., Knudsen J.D., et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol 2011, 49:3300-3308.
3. Cortés J.A., Reyes P., Gómez C., Buitrago G., Leal A.L. Fungal bloodstream infections in tertiary care hospitals in Colombia. Rev Iberoam Micol 2011, 28:74-78. GREBO Group.
4. Miceli M.H., Díaz J.A., Lee S.A. Emerging opportunistic yeast infections. Lancet Infect Dis 2011, 11:142-151.